| 0 |
SUBACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY |
1 |
0.0294 |
| 1 |
ACNE FULMINANS |
1 |
0.0051 |
| 2 |
FAILURE TO SUSPEND MEDICATION |
1 |
0.0048 |
| 3 |
POLYCHONDRITIS |
1 |
0.0024 |
| 4 |
DEVICE SAFETY FEATURE ISSUE |
2 |
0.0020 |
| 5 |
RETINAL VASCULAR DISORDER |
1 |
0.0017 |
| 6 |
SITTING DISABILITY |
1 |
0.0016 |
| 7 |
GLOMERULONEPHRITIS MINIMAL LESION |
1 |
0.0014 |
| 8 |
MALIGNANT ASCITES |
1 |
0.0013 |
| 9 |
EOSINOPHILIC PNEUMONIA ACUTE |
1 |
0.0012 |
| 10 |
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE |
1 |
0.0009 |
| 11 |
ADENOCARCINOMA PANCREAS |
1 |
0.0008 |
| 12 |
PRODUCT LEAKAGE |
4 |
0.0007 |
| 13 |
CLEFT PALATE |
1 |
0.0005 |
| 14 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
1 |
0.0004 |
| 15 |
DEVICE MALFUNCTION |
28 |
0.0004 |
| 16 |
ACCIDENTAL EXPOSURE TO PRODUCT |
34 |
0.0003 |
| 17 |
PYODERMA GANGRENOSUM |
1 |
0.0003 |
| 18 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 19 |
DEVICE FAILURE |
4 |
0.0003 |
| 20 |
DEVICE LEAKAGE |
11 |
0.0003 |
| 21 |
POLYDIPSIA |
1 |
0.0003 |
| 22 |
PRODUCT COMPLAINT |
6 |
0.0002 |
| 23 |
ABSCESS LIMB |
1 |
0.0002 |
| 24 |
DEVICE OPERATIONAL ISSUE |
1 |
0.0002 |
| 25 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 26 |
HYPERAMMONAEMIA |
1 |
0.0002 |
| 27 |
DRUG DELIVERY SYSTEM MALFUNCTION |
1 |
0.0002 |
| 28 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 29 |
INJECTION SITE DISCHARGE |
1 |
0.0002 |
| 30 |
DEVICE DEFECTIVE |
3 |
0.0002 |
| 31 |
INJECTION SITE IRRITATION |
2 |
0.0002 |
| 32 |
DEVICE DEPLOYMENT ISSUE |
2 |
0.0002 |
| 33 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 34 |
INJURY ASSOCIATED WITH DEVICE |
3 |
0.0001 |
| 35 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 36 |
PRODUCT DOSE OMISSION ISSUE |
31 |
0.0001 |
| 37 |
NO ADVERSE EVENT |
15 |
0.0001 |
| 38 |
INJECTION SITE URTICARIA |
2 |
0.0001 |
| 39 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 40 |
SKIN REACTION |
1 |
0.0001 |
| 41 |
NEEDLE ISSUE |
2 |
0.0001 |
| 42 |
PRODUCT QUALITY ISSUE |
9 |
0.0001 |
| 43 |
BRAIN FOG |
1 |
0.0001 |
| 44 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 45 |
DEVICE USE ERROR |
2 |
0.0001 |
| 46 |
SYRINGE ISSUE |
1 |
0.0001 |
| 47 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 48 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 49 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 50 |
PSORIATIC ARTHROPATHY |
2 |
0.0000 |
| 51 |
DEVICE DIFFICULT TO USE |
3 |
0.0000 |
| 52 |
DEVICE ISSUE |
4 |
0.0000 |
| 53 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 54 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 55 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 56 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 57 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 58 |
RASH MACULAR |
1 |
0.0000 |
| 59 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 60 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 61 |
DYSARTHRIA |
1 |
0.0000 |
| 62 |
DRUG DOSE OMISSION BY DEVICE |
2 |
0.0000 |
| 63 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 64 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 65 |
MENTAL DISORDER |
1 |
0.0000 |
| 66 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 67 |
HYPOKALAEMIA |
1 |
0.0000 |
| 68 |
RASH PRURITIC |
1 |
0.0000 |
| 69 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 70 |
INCORRECT DOSE ADMINISTERED |
4 |
0.0000 |
| 71 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 72 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 73 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 74 |
MOBILITY DECREASED |
1 |
0.0000 |
| 75 |
HOT FLUSH |
1 |
0.0000 |
| 76 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 77 |
ACNE |
1 |
0.0000 |
| 78 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 79 |
MYALGIA |
2 |
0.0000 |
| 80 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 81 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 82 |
ADVERSE EVENT |
1 |
0.0000 |
| 83 |
DYSPHAGIA |
1 |
0.0000 |
| 84 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 85 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 86 |
ILLNESS |
1 |
0.0000 |
| 87 |
HAEMORRHAGE |
1 |
0.0000 |
| 88 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 89 |
RASH |
3 |
0.0000 |
| 90 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 91 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 92 |
PAIN |
4 |
0.0000 |
| 93 |
PARAESTHESIA |
1 |
0.0000 |
| 94 |
PYREXIA |
2 |
0.0000 |
| 95 |
MUSCLE SPASMS |
1 |
0.0000 |
| 96 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 97 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 98 |
ANAEMIA |
1 |
0.0000 |
| 99 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 100 |
ARTHRALGIA |
2 |
0.0000 |
| 101 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 102 |
DRUG INEFFECTIVE |
5 |
0.0000 |
| 103 |
WEIGHT DECREASED |
1 |
0.0000 |
| 104 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 105 |
HEADACHE |
2 |
0.0000 |
| 106 |
DIARRHOEA |
2 |
0.0000 |
| 107 |
ASTHENIA |
1 |
0.0000 |
| 108 |
PRURITUS |
1 |
0.0000 |
| 109 |
FATIGUE |
2 |
0.0000 |
| 110 |
OFF LABEL USE |
2 |
0.0000 |
| 111 |
MALAISE |
1 |
0.0000 |
| 112 |
NAUSEA |
1 |
0.0000 |
| 113 |
DEATH |
1 |
0.0000 |